Ex Parte Munro et al - Page 11


                 Appeal No. 2006-0483                                                                                                               
                 Application 09/860,272                                                                                                             

                          The examiner has indicated that claims 16, 17, 23 and 24 are allowable over the applied                                   
                 prior art.  We find that the principal difference between these claims and appealed claim 1 is the                                 
                 monomers specified therein.  We find that the specified monomers of these claims are include                                       
                 within the teachings of monomers in Mercurio, Nguyen and Sekiya.  Accordingly, prima facie,                                        
                 one of ordinary skill in the art routinely following the teachings of these references would have                                  
                 reasonably arrived at the claimed coating compositions encompassed by these claims on the                                          
                 same basis that the examiner set forth in the grounds of rejection that we affirmed above.  See                                    
                 Merck & Co., Inc. v. Biocraft Labs., Inc., 874 F.2d 804, 807, 10 USPQ2d 1843, 1845-46 (Fed.                                        
                 Cir. 1989) (“That the ‘813 patent discloses a multitude of effective combinations does not render                                  
                 any particular formulation less obvious. This is especially true because the claimed composition                                   
                 is used for the identical purpose.”); In re Susi, 440 F.2d 442, 445, 169 USPQ 423, 425 (CCPA                                       
                 1971) (“As appellant points out, Lauerer’s disclosure is huge, but it undeniably includes at least                                 
                 some of the compounds recited in appellant’s generic claims and is of a class of chemicals to be                                   
                 used for the same purpose as appellant’s additives.”); In re Lemin, 332 F.2d 839, 841, 141 USPQ                                    
                 814, 815-16 (CCPA 1964)(“Generally speaking there is nothing unobvious in choosing ‘some’                                          
                 among ‘many’ indiscriminately.”).                                                                                                  
                          Furthermore, we find that, prima facie, Kuwajima (e.g., cols. 3-11 and Examples 1,                                        
                 13 and 14) and Kumacheva (e.g., [0016], [0017], [0028] through [0034] and Example 1, [0090]                                        
                 through [0092]), would have disclosed to one of ordinary skill in this art coating compositions                                    
                 falling within the appealed claims 1 through 4, 7 through 19, 23 through 25 and 27 through 31.                                     
                          We decline to exercise our authority under 37 CFR § 41.50(b) (2005) with respect to                                       
                 these matters, leaving it to the examiner to apply the references to the claims upon any further                                   
                 prosecution of the appealed claims before the examiner upon the disposition of this appeal.                                        
                          No time period for taking any subsequent action in connection with this appeal may be                                     
                 extended under 37 CFR § 1.136(a)(1)(iv) (2005).                                                                                    
                                                            AFFIRMED-IN-PART                                                                        
                                                                  REMANDED                                                                          





                                                                      - 11 -                                                                        



Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  Next 

Last modified: November 3, 2007